Tag: biosimilars billing
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.
Medications
Archives
Recent-posts
Foreign Manufacturing of Generics: FDA Oversight and Standards in 2025
Dec, 17 2025
Epilepsy and Seizures: Types, Triggers, and Antiepileptic Medications
Mar, 23 2026
Diacerein vs Alternatives: In‑Depth Comparison for Osteoarthritis
Oct, 25 2025
Buy Generic Claritin (Loratadine) Online Cheap: Safe 2025 Prices, Deals, and Buyer’s Guide
Sep, 9 2025
Actos: Everything You Need to Know About Pioglitazone for Type 2 Diabetes
Jun, 5 2025